By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Nanosphere has closed a public offering of common stock raising net proceeds of approximately $32.1 million, the firm said today.

The Northbrook, Ill.-based molecular diagnostics developer sold 15,686,000 shares of common stock at a price of $2.20 per share. Included in that share total is 2,046,000 shares issued to cover an over-allotment option.

Nanosphere said that it would use the funds for general corporate purposes and working capital.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.